Login / Signup

Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine.

Viktória MeszárGabriella MagyarGabriella Mészárosné PásztorBalázs SzatmáriKrisztina PéterLívia MartonZsófia B DombiÁgota Barabássy
Published in: Pharmacopsychiatry (2024)
The result of this clinical trial proved the bioequivalence of the new orodispersible tablet formulation when compared to hard gelatine capsules, enabling an alternative option for treatment of those suffering from schizophrenia.
Keyphrases
  • clinical trial
  • drug delivery
  • bipolar disorder
  • open label
  • double blind
  • phase iii